155 related articles for article (PubMed ID: 23801632)
1. β-Catenin activation synergizes with Pten loss and Myc overexpression in Notch-independent T-ALL.
Kaveri D; Kastner P; Dembélé D; Nerlov C; Chan S; Kirstetter P
Blood; 2013 Aug; 122(5):694-704. PubMed ID: 23801632
[TBL] [Abstract][Full Text] [Related]
2. Murine Pten(-/-) T-ALL requires non-redundant PI3K/mTOR and DLL4/Notch1 signals for maintenance and γc/TCR signals for thymic exit.
Hagenbeek TJ; Wu X; Choy L; Sanchez-Irizarry C; Seshagiri S; Stinson J; Siebel CW; Spits H
Cancer Lett; 2014 May; 346(2):237-48. PubMed ID: 24384093
[TBL] [Abstract][Full Text] [Related]
3. Miltefosine suppression of Pten null T-ALL leukemia via β-catenin degradation through inhibition of pT308-Akt and TGFβ1/Smad3.
Zhang Y; Lee S; Xu W
Biochem Biophys Res Commun; 2020 Apr; 524(4):1018-1024. PubMed ID: 32063363
[TBL] [Abstract][Full Text] [Related]
4. Revisiting β-Catenin Signaling in T-Cell Development and T-Cell Acute Lymphoblastic Leukemia.
Bigas A; Guillén Y; Schoch L; Arambilet D
Bioessays; 2020 Feb; 42(2):e1900099. PubMed ID: 31854474
[TBL] [Abstract][Full Text] [Related]
5. Acute T-cell leukemias remain dependent on Notch signaling despite PTEN and INK4A/ARF loss.
Medyouf H; Gao X; Armstrong F; Gusscott S; Liu Q; Gedman AL; Matherly LH; Schultz KR; Pflumio F; You MJ; Weng AP
Blood; 2010 Feb; 115(6):1175-84. PubMed ID: 20008304
[TBL] [Abstract][Full Text] [Related]
6. Suppression of leukemia development caused by PTEN loss.
Guo W; Schubbert S; Chen JY; Valamehr B; Mosessian S; Shi H; Dang NH; Garcia C; Theodoro MF; Varella-Garcia M; Wu H
Proc Natl Acad Sci U S A; 2011 Jan; 108(4):1409-14. PubMed ID: 21212363
[TBL] [Abstract][Full Text] [Related]
7. Calcium Signaling Is Impaired in PTEN-Deficient T Cell Acute Lymphoblastic Leukemia.
Pankaew S; Potier D; Grosjean C; Nozais M; Quessada J; Loosveld M; Remy É; Payet-Bornet D
Front Immunol; 2022; 13():797244. PubMed ID: 35185889
[TBL] [Abstract][Full Text] [Related]
8. Posttranscriptional deregulation of MYC via PTEN constitutes a major alternative pathway of MYC activation in T-cell acute lymphoblastic leukemia.
Bonnet M; Loosveld M; Montpellier B; Navarro JM; Quilichini B; Picard C; Di Cristofaro J; Bagnis C; Fossat C; Hernandez L; Mamessier E; Roulland S; Morgado E; Formisano-Tréziny C; Dik WA; Langerak AW; Prebet T; Vey N; Michel G; Gabert J; Soulier J; Macintyre EA; Asnafi V; Payet-Bornet D; Nadel B
Blood; 2011 Jun; 117(24):6650-9. PubMed ID: 21527520
[TBL] [Abstract][Full Text] [Related]
9. Pten deletion in Dmp1-expressing cells does not rescue the osteopenic effects of Wnt/β-catenin suppression.
Lim KE; Hoggatt AM; Bullock WA; Horan DJ; Yokota H; Pavalko FM; Robling AG
J Cell Physiol; 2020 Dec; 235(12):9785-9794. PubMed ID: 32529635
[TBL] [Abstract][Full Text] [Related]
10. Tcf-1 promotes genomic instability and T cell transformation in response to aberrant β-catenin activation.
Arnovitz S; Mathur P; Tracy M; Mohsin A; Mondal S; Quandt J; Hernandez KM; Khazaie K; Dose M; Emmanuel AO; Gounari F
Proc Natl Acad Sci U S A; 2022 Aug; 119(32):e2201493119. PubMed ID: 35921443
[TBL] [Abstract][Full Text] [Related]
11. Axis inhibition protein 1 (Axin1) Deletion-Induced Hepatocarcinogenesis Requires Intact β-Catenin but Not Notch Cascade in Mice.
Qiao Y; Wang J; Karagoz E; Liang B; Song X; Shang R; Evert K; Xu M; Che L; Evert M; Calvisi DF; Tao J; Wang B; Monga SP; Chen X
Hepatology; 2019 Dec; 70(6):2003-2017. PubMed ID: 30737831
[TBL] [Abstract][Full Text] [Related]
12. Single-cell profiling of pediatric T-cell acute lymphoblastic leukemia: Impact of PTEN exon 7 mutation on PI3K/Akt and JAK-STAT signaling pathways.
Bonaccorso P; Bugarin C; Buracchi C; Fazio G; Biondi A; Lo Nigro L; Gaipa G
Cytometry B Clin Cytom; 2020 Nov; 98(6):491-503. PubMed ID: 32479694
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B virus-triggered PTEN/β-catenin/c-Myc signaling enhances PD-L1 expression to promote immune evasion.
Sun Y; Yu M; Qu M; Ma Y; Zheng D; Yue Y; Guo S; Tang L; Li G; Zheng W; Wang M; Guo D; Li C
Am J Physiol Gastrointest Liver Physiol; 2020 Jan; 318(1):G162-G173. PubMed ID: 31604033
[TBL] [Abstract][Full Text] [Related]
14. Beta-catenin stabilization stalls the transition from double-positive to single-positive stage and predisposes thymocytes to malignant transformation.
Guo Z; Dose M; Kovalovsky D; Chang R; O'Neil J; Look AT; von Boehmer H; Khazaie K; Gounari F
Blood; 2007 Jun; 109(12):5463-72. PubMed ID: 17317856
[TBL] [Abstract][Full Text] [Related]
15. Cooperation between both Wnt/{beta}-catenin and PTEN/PI3K/Akt signaling promotes primitive hematopoietic stem cell self-renewal and expansion.
Perry JM; He XC; Sugimura R; Grindley JC; Haug JS; Ding S; Li L
Genes Dev; 2011 Sep; 25(18):1928-42. PubMed ID: 21890648
[TBL] [Abstract][Full Text] [Related]
16. NOTCH and phosphatidylinositide 3-kinase/phosphatase and tensin homolog deleted on chromosome ten/AKT/mammalian target of rapamycin (mTOR) signaling in T-cell development and T-cell acute lymphoblastic leukemia.
Guo D; Teng Q; Ji C
Leuk Lymphoma; 2011 Jul; 52(7):1200-10. PubMed ID: 21463127
[TBL] [Abstract][Full Text] [Related]
17. LZTS2 and PTEN collaboratively regulate ß-catenin in prostatic tumorigenesis.
Yu EJ; Hooker E; Johnson DT; Kwak MK; Zou K; Luong R; He Y; Sun Z
PLoS One; 2017; 12(3):e0174357. PubMed ID: 28323888
[TBL] [Abstract][Full Text] [Related]
18. Integrated β-catenin, BMP, PTEN, and Notch signalling patterns the nephron.
Lindström NO; Lawrence ML; Burn SF; Johansson JA; Bakker ER; Ridgway RA; Chang CH; Karolak MJ; Oxburgh L; Headon DJ; Sansom OJ; Smits R; Davies JA; Hohenstein P
Elife; 2015 Feb; 3():e04000. PubMed ID: 25647637
[TBL] [Abstract][Full Text] [Related]
19. Notch1 gene mutations target KRAS G12D-expressing CD8+ cells and contribute to their leukemogenic transformation.
Kong G; Du J; Liu Y; Meline B; Chang YI; Ranheim EA; Wang J; Zhang J
J Biol Chem; 2013 Jun; 288(25):18219-27. PubMed ID: 23673656
[TBL] [Abstract][Full Text] [Related]
20. TLX1 and NOTCH coregulate transcription in T cell acute lymphoblastic leukemia cells.
Riz I; Hawley TS; Luu TV; Lee NH; Hawley RG
Mol Cancer; 2010 Jul; 9():181. PubMed ID: 20618946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
